A carregar...
Evaluating vandetanib in the treatment of medullary thyroid cancer: patient-reported outcomes
Medullary thyroid cancers (MTCs) are neuroendocrine tumors, which secrete calcitonin and carcinoembryonic antigen, both of which can serve as tumor markers. Extensive and accurate surgical resection is the primary treatment for MTC, whereas the use of external beam radiotherapy is limited. Moreover,...
Na minha lista:
| Publicado no: | Cancer Manag Res |
|---|---|
| Main Authors: | , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6708888/ https://ncbi.nlm.nih.gov/pubmed/31686907 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CMAR.S127848 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|